板蓝根与大青叶:民族药理、植物化学与药理的系统综述
该综述系统汇总板蓝根(BLG)与大青叶(DQY)的民族药理、植物化学、药理、毒性及临床应用信息,检索多个数据库及药典等文献。结果显示两者共含304与142种化合物,主要差异在生物碱与木脂素类;板蓝根抗病毒与免疫调节更强,大青叶抗氧化更强,为分开列载提供依据。
要点
- 板蓝根抗病毒与免疫调节活性强于大青叶,大青叶抗氧化活性更高。
- 2020版中国药典分别以(R,S)-告依春和靛玉红作为板蓝根与大青叶的质量标志物。
- 两者主要化学差异集中于生物碱与木脂素类成分,支持分开列载。
核心结论
- 板蓝根与大青叶主要共有化合物为生物碱,近期植物化学与药理研究证实其传统抗病毒、抗菌及治疗免疫疾病用途。
- 两者在民族药理、植物化学与药理上的显著差异可作为分开列载的依据。
研究设计与样本
- 系统综述,检索Google Scholar、PubMed、百度学术、GeenMedical、CNKI和Web of Science等数据库及相关教材、综述和文件(如2020版中国药典、中药经典著作及学位论文等)。
主要发现
- 截至数据收集,基于NMPA数据已开发39种含板蓝根和/或大青叶的中成药。
- 板蓝根中发现304种化合物,大青叶中发现142种化合物。
- 两者主要化学差异集中在生物碱与木脂素类,如靛蓝、靛玉红、(R,S)-表告依春、4(3H)-喹唑啉酮、clemastanin B和isatindigotindolines A-D。
- 现代药理主要研究4(3H)-喹唑啉酮、clemastanin B、芥酸和腺苷等单体成分,均显示良好效果,可抗流感病毒、呼吸道合胞病毒、单纯疱疹病毒等,并通过调节免疫水平和多种炎症因子抑制病毒生长繁殖。
- 不同成分导致板蓝根抗病毒和免疫调节活性强于大青叶,而大青叶抗氧化活性强度高于板蓝根。
关键数值与推荐
- 2020版中国药典分别以(R,S)-告依春和靛玉红作为板蓝根和大青叶的官方质量监测标志物。
临床怎么用
- 临床可依据板蓝根抗病毒与免疫调节更强、大青叶抗氧化更强的特点区分使用。
- 含板蓝根和/或大青叶的中成药已有39种,可结合药典标志物进行质量把控。
局限性
- 综述指出需设计更全面的研究以进一步利用板蓝根和大青叶。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Isatidis Radix (called Banlangen, BLG in Chinese) and Isatidis Folium (called Daqingye, DQY in Chinese) are common traditional edible-medicinal herbs in detoxifying for thousands of years, have been traditionally applied in traditional Chinese medicine for centuries. Both of them are bitter in taste, coolness in nature, acting on the heart and stomach channels. They are often used to treat influenza and other viral infectious diseases in clinic, as well as could treat fever, dizziness, and cough and sore throat caused by lung heat. AIMS OF THE REVIEW: This review aimed at summarizing the latest and comprehensive information of BLG and DQY on the ethnopharmacology, phytochemistry, pharmacology, toxicity and clinical application to explore the therapeutic potential of them. In addition, outlooks and perspective for possible future researches that related are also discussed. MATERIALS AND METHODS: Related information concerning BLG and DQY were gathered from the internet database of Google Scholar, PubMed, Baidu Scholar, GeenMedical, CNKI and Web of Science, as well as other relevant textbooks, reviews, and documents (e.g., Chinese Pharmacopoeia, 2020 edition, Chinese herbal classic books and PhD and MSc thesis, etc.). Among of them with the keywords including "Isatis indigotica" "Isatidis Radix", "Isatidis Folium", "phytochemistry", "pharmacology", "toxicology", "clinical application" etc. and their combinations. RESULTS: To date, 39 Chinese patent medicines containing BLG and/or DQY have been developed on basis of the data of NMPA. Besides, 304 and 142 compounds have been found in BLG and DQY, respectively. The main chemical differences between BLG and DQY were concentrated on alkaloids and lignans, such as indican, indirubin, (R, S)-epigoitrin, 4(3H)-quinazolinone, clemastanin B and isatindigotindolines A-D. In 2020 Edition ChP, (R, S)-goitrin and indirubin are now used as the official marker to monitor the quality of BLG and DQY, respectively. Modern pharmacology has mainly studied some monomer components such as 4(3H)-quinazolinone, clemastanin B, erucic acid and adenosine, etc., all of which have shown good effects. These active compounds can resist various viruses, such as influenza virus, respiratory syncytial virus, herpes simplex virus, etc.. By regulating the level of immunity and a variety of inflammatory factors, inhibit the growth and reproduction of the virus. At the same time, it is worth noting that different components of BLG and DQY lead to BLG is more powerful in antiviral and immunomodulatory activity than DQY, while DQY possesses a higher intensity than BLG in anti-oxidant activity. CONCLUSION: By collecting and collating a large number of literature and various data websites, we concluded that the common compounds are mainly alkaloids. Recent findings regarding the phytochemical and pharmacological properties of BLG and DQY have confirmed their traditional uses in antiviral, antibacterial and treatment immune diseases. Without doubt, their significant differences on ethnopharmacology, phytochemistry and pharmacology can be used as evidence of separate list of BLG and DQY. For shortcomings, some comprehensive studies should be well designed for further utilization of BLG and DQY.
引用
- Chen J, Zhu Z, Gao T, et al. Isatidis Radix and Isatidis Folium: A systematic review on ethnopharmacology, phytochemistry and pharmacology. J Ethnopharmacol. 2021. PMID: 34543684. doi:10.1016/j.jep.2021.114648
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。